RDGL Projected Dividend Yield
Vivos Inc ( OTCBB : RDGL )Vivos Inc. is a radiation oncology medical device company. Co. is engaged in the development of its yttrium-90 (Y-90) based brachytherapy device, RadioGel, for the treatment of non-resectable tumors. RadioGel is a device for human therapy for non-resectable cancers in humans. It is a hydrogel liquid containing tiny Yttrium-90 phosphate microparticles that may be administered directly into a tumor. Co.'s IsoPet division is focused on bringing RadioGel yttrium-90 precision radionuclide therapy to veterinary oncologists to treat dogs, cats and horses suffering from cancerous tumors. 20 YEAR PERFORMANCE RESULTS |
RDGL Dividend History Detail RDGL Dividend News RDGL Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |